Gsa Capital Partners LLP Mimedx Group, Inc. Transaction History

Gsa Capital Partners LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$6.16 - $8.08 $560,467 - $735,158	90,985 New	90,985 $631,000
Q4 2023 Feb 16, 2024	BUY	$5.7 - $9.14 $171,319 - $274,711	30,056 New	30,056 $263,000
Q2 2023 Aug 14, 2023	BUY	$3.14 - $6.61 $90,727 - $190,989	28,894 New	28,894 $190,000
Q1 2022 May 11, 2022	SELL	$4.27 - $6.27 $119,952 - $176,136	-28,092 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.7 - $8.48 $160,124 - $238,220	28,092 New	28,092 $170,000
Q4 2018 Feb 12, 2019	SELL	$1.15 - $6.45 $359,417 - $2.02 Million	-312,537 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.22 - $6.33 $204,589 - $402,189	63,537 Added 25.52%	312,537 $1.93 Million
Q2 2018 Aug 09, 2018	SELL	$5.39 - $8.96 $202,664 - $336,896	-37,600 Reduced 13.12%	249,000 $1.59 Million
Q1 2018 May 11, 2018	BUY	$6.69 - $17.96 $531,667 - $1.43 Million	79,472 Added 38.37%	286,600 $2 Million
Q4 2017 Feb 14, 2018	BUY	$10.87 - $13.9 $1.24 Million - $1.59 Million	114,428 Added 123.44%	207,128 $2.61 Million
Q3 2017 Nov 20, 2017	BUY	$11.86 - $17.34 $1.1 Million - $1.61 Million	92,700	92,700 $1.1 Million

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.